Currax is a biopharmaceutical company that delivers acquiring and commercializing prescription drugs to the healthcare sectors... Read more
Currax is a biopharmaceutical company that delivers acquiring and commercializing prescription drugs to the healthcare sectors... Read more
News
Mar 22, 2025
Pharmabiz
Currax Pharmaceuticals: US FDA approves Currax Pharmaceuticals' second drug manufacturing site for Contrave/Mysimba to enhance production capacity
Feb 25, 2025
Benzinga
Currax Pharmaceuticals: Currax Provides Update on Litigation Against Found Health Inc.
Feb 14, 2025
The Business Journals: Nashville
Currax Pharmaceuticals: CEO George Hampton: Currax Pharmaceutical reports 50% year-over-year growth
Jan 10, 2025
PR Newswire
Press Release: Currax Pharmaceuticals : Currax Announces Outstanding 2024 Financial and Operational Performance
Jan 02, 2025
PR Newswire
Press Release: Currax Pharmaceuticals : Currax Introduces First CONTRAVE TV Ad and "Cravings Don't Own Me" Campaign, Highlighting Food Cravings Management and Weight Loss
Aug 27, 2024
FinanzNachrichten
Currax Pharmaceuticals: Currax Pharmaceuticals LLC: Currax Pharmaceuticals: CONTRAVE/MYSIMBA Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study
Jul 23, 2024
EIN Presswire
Press Release: Currax Pharmaceuticals : New Facility Assures Continuity of Supply of Anti-Obesity Treatment CONTRAVE/MYSIMBA Amidst GLP-1 Supply Issues
Apr 04, 2024
MedicalMarketing& Media
Currax Pharmaceuticals: Currax Pharmaceuticals CEO: GLP-1 drugs lift entire weight loss category
Jan 25, 2024
EIN Presswire
Press Release: Currax Pharmaceuticals : Currax Pharmaceuticals Announces First Patient Screened into the INFORMUS Cardiovascular Outcomes Trial
Oct 18, 2023
Life Care News
Currax Pharmaceuticals: Currax Pharmaceuticals: CONTRAVE/MYSIMBA demonstrates no increased risk in major adverse cardiac events in a large, long-term real-world evidence study